Qualifying vs verifying vs validating multi-level networked models

• In: ROUND TABLE: THE ROLE OF BIOPHARMACEUTICAL TOOLS IN QUALITY BY DESIGN on Monday, 14 April 2014, 16:00-17:30
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: ROSTAMI-HODJEGAN, Amin (University of Manchester, Manchester School of Pharmacy, Manchester, United Kingdom)
• Abstract:

  Modelling and simulation (M&S) is becoming part and parcel of new drug discovery and development paradigm in multi-layers (Vicini 2011). The move towards 'mechanistic models' (as opposed to pharmaco-statistical models) has been an obvious trend in recent years. One of the areas which has moved rapidly and gained regulatory acceptance is the area

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login